Changes in the Systemic Expression of Sirtuin-1 and Oxidative Stress after Intravitreal Anti-Vascular Endothelial Growth Factor in Patients with Retinal Vein Occlusion
暂无分享,去创建一个
Shih-Jen Chen | Ching-Yao Tsai | Kuan-Hsuan Chen | Yuh-Lih Chang | Chi-Hsien Peng | Tai-Chi Lin | De-Kuang Hwang | Ke-Hung Chien | Min-Yen Hsu
[1] Shih-Jen Chen,et al. Elevation of serum oxidative stress in patients with retina vein occlusions , 2018, Acta ophthalmologica.
[2] A. Koytak,et al. Oxidant-Antioxidant Balance in the Aqueous Humor of Patients with Retinal Vein Occlusion , 2018, Seminars in ophthalmology.
[3] Takao Hirano,et al. CHANGES IN PLASMA VASCULAR ENDOTHELIAL GROWTH FACTOR LEVEL AFTER INTRAVITREAL INJECTION OF BEVACIZUMAB, AFLIBERCEPT, OR RANIBIZUMAB FOR DIABETIC MACULAR EDEMA , 2017, Retina.
[4] Enzhong Jin,et al. SERUM LEVELS OF VASCULAR ENDOTHELIAL GROWTH FACTOR BEFORE AND AFTER INTRAVITREAL INJECTION OF RANIBIZUMAB OR CONBERCEPT FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION , 2017, Retina.
[5] Wei-Chi Wu,et al. SERUM VASCULAR ENDOTHELIAL GROWTH FACTOR AFTER BEVACIZUMAB OR RANIBIZUMAB TREATMENT FOR RETINOPATHY OF PREMATURITY , 2017, Retina.
[6] D. Đikić,et al. Levels of selected oxidative stress markers in the vitreous and serum of diabetic retinopathy patients , 2015, Molecular vision.
[7] X. Xia,et al. Suppression of retinal neovascularization by small interfering RNA targeting PGC-1α. , 2014, International journal of molecular medicine.
[8] M. Monsalve,et al. SirT1 regulation of antioxidant genes is dependent on the formation of a FoxO3a/PGC-1α complex. , 2013, Antioxidants & redox signaling.
[9] T. Suuronen,et al. Antagonistic crosstalk between NF-κB and SIRT1 in the regulation of inflammation and metabolic disorders. , 2013, Cellular signalling.
[10] R. Caldwell,et al. Diabetes-Induced Superoxide Anion and Breakdown of the Blood-Retinal Barrier: Role of the VEGF/uPAR Pathway , 2013, PloS one.
[11] Louis K. Chang,et al. Inflammation in Retinal Vein Occlusion , 2013, International journal of inflammation.
[12] T. Mimura,et al. Association of inflammatory factors with macular edema in branch retinal vein occlusion. , 2013, JAMA ophthalmology.
[13] A. Jiang,et al. PGC-1α regulates normal and pathological angiogenesis in the retina. , 2013, The American journal of pathology.
[14] Li Su,et al. Improvement of Retinal Vascular Injury in Diabetic Rats by Statins Is Associated With the Inhibition of Mitochondrial Reactive Oxygen Species Pathway Mediated by Peroxisome Proliferator–Activated Receptor γ Coactivator 1α , 2010, Diabetes.
[15] F. Alt,et al. SIRT1 controls endothelial angiogenic functions during vascular growth. , 2007, Genes & development.
[16] A. Sepici-Dinçel,et al. Antioxidant Enzymes and Diabetic Retinopathy , 2007, Annals of the New York Academy of Sciences.
[17] Don H. Anderson,et al. Age‐related macular degeneration—emerging pathogenetic and therapeutic concepts , 2006, Annals of medicine.
[18] S. Fekrat,et al. Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion. , 2004, American journal of ophthalmology.
[19] J. Jonas,et al. Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion , 2002, Graefe’s Archive for Clinical and Experimental Ophthalmology.
[20] P. Mitchell,et al. Prevalence and associations of retinal vein occlusion in Australia. The Blue Mountains Eye Study. , 1996, Archives of ophthalmology.
[21] E. Kohner,et al. Measurement of blood-retinal barrier function in central retinal vein occlusion. , 1986, Archives of ophthalmology.
[22] Ingrid U. Scott,et al. Retinal vein occlusion. , 2010, British medical journal.